Injective co-founder Eric at the New York Stock ExchangeCatch a clip below where Eric discusses the recent launch of iAssets

Injective Announcements

Injective co-founder Eric at the New York Stock Exchange

Catch a clip below where Eric discusses the recent launch of iAssets, enabling Injective to be the first L1 capable of offering onchain stocks and bonds in a fully permissionless manner.

https://x.com/injective/status/1901729161993232664

X (formerly Twitter)

Injective 🥷 (@injective) on X

Injective co-founder @ericinjective at the @NYSE.

Catch a clip below where Eric discusses the recent launch of iAssets, enabling Injective to be the first L1 capable of offering onchain stocks and bonds in a fully permissionless manner.

www.tg-me.com/us/Injective Announcements/com.injectiveann/1197

2.2K viewsMar 17 at 20:24

tg-me.com/injectiveann/1197

Create: 2025-03-17
Last Update: 2025-06-01 10:51:08

BY Injective Announcements

Share with your friend now:
tg-me.com/injectiveann/1197

Injective Announcements Telegram | DID YOU KNOW?

Importantly, that investor viewpoint is not new. It cycles in when conditions are right (and vice versa). It also brings the ineffective warnings of an overpriced market with it.Looking toward a good 2022 stock market, there is no apparent reason to expect these issues to change.